Evidence map›Paper›PMID 26992050›Full record

Trial reportMolecular nutrition & food research2016

Polyphenol rich olive oils improve lipoprotein particle atherogenic ratios and subclasses profile: A randomized, crossover, controlled trial.

Sara Fernández-Castillejo, Rosa-Maria Valls, Olga Castañer, Laura Rubió, Úrsula Catalán, Anna Pedret, Alba Macià, Maureen L Sampson, María-Isabel Covas, Montserrat Fitó and 3 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Molecular nutrition & food research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 60 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Sara Fernández-CastillejoResearch Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut Investigació Sanitària Pere Virgili, NFOC group, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, CIBERDEM, Reus, Spain.
Rosa-Maria VallsResearch Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut Investigació Sanitària Pere Virgili, NFOC group, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, CIBERDEM, Reus, Spain.
Olga CastañerCardiovascular Risk and Nutrition Research group, IMIM- Institut Hospital del Mar d'Investigacions Mèdiques, CIBEROBN, Barcelona, Spain.
Laura RubióResearch Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut Investigació Sanitària Pere Virgili, NFOC group, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, CIBERDEM, Reus, Spain.
Úrsula CatalánResearch Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut Investigació Sanitària Pere Virgili, NFOC group, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, CIBERDEM, Reus, Spain.
Anna PedretResearch Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut Investigació Sanitària Pere Virgili, NFOC group, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, CIBERDEM, Reus, Spain.
Alba MaciàFood Technology Department; Agrotecnio Center, University of Lleida, Lleida, Spain.
Maureen L SampsonDepartment of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
María-Isabel CovasCardiovascular Risk and Nutrition Research group, IMIM- Institut Hospital del Mar d'Investigacions Mèdiques, CIBEROBN, Barcelona, Spain.
Montserrat FitóCardiovascular Risk and Nutrition Research group, IMIM- Institut Hospital del Mar d'Investigacions Mèdiques, CIBEROBN, Barcelona, Spain.
Maria-José MotilvaFood Technology Department; Agrotecnio Center, University of Lleida, Lleida, Spain.
Alan T RemaleyDepartment of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.
Rosa SolàResearch Unit on Lipids and Atherosclerosis, Hospital Universitari Sant Joan, Institut Investigació Sanitària Pere Virgili, NFOC group, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, CIBERDEM, Reus, Spain.
Universidad Rovira i Virgili · ESHospital del Mar Research Institute · ESInstitut d'Investigació Sanitària Pere Virgili · ESNational Institutes of Health Clinical Center · USUniversitat de Lleida · ESCentro de Investigación Biomédica en Red · ES

Funding

Development Of New Assays For Lipoprotein TestingZIACL010303 · CLC · CLINICAL CENTER · PI REMALEY, ALAN THOMAS · 2009 to 2017
$0k
Intramural NIH HHS ZIA CL010303
6 · The paper itself

Abstract

scopeLipoprotein particle measures performed by nuclear magnetic resonance (NMR), and associated ratios, may be better markers for atherosclerosis risk than conventional lipid measures. The effect of two functional olive oils, one enriched with its polyphenols (FVOO, 500 ppm), and the other (FVOOT) with them (250 ppm) and those of thyme (250 ppm), versus a standard virgin olive oil (VOO), on lipoprotein particle atherogenic ratios and subclasses profiles was assessed. METHODS AND

resultsIn a randomized, double-blind, crossover, controlled trial, 33 hypercholesterolemic individuals received 25 mL/day of VOO, FVOO, and FVOOT. Intervention periods were of 3 weeks separated by 2-week washout periods. Lipoprotein particle counts and subclasses were measured by NMR. Polyphenols from olive oil and thyme modified the lipoprotein subclasses profile and decreased the total LDL particle/total HDL particle (HDL-P), small HDL/large HDL, and HDL-cholesterol/HDL-P ratios, and decreased the lipoprotein insulin resistance index (LP-IR) (p < 0.05).

conclusionOlive oil polyphenols, and those from thyme provided benefits on lipoprotein particle atherogenic ratios and subclasses profile distribution. Polyphenol-enriched olive oil is a way of increasing the olive oil healthy properties while consuming the same amount of fat, as well as a useful and complementary tool for the management of cardiovascular risk individuals.

Indexed as

DietAdultAgedAtherosclerosisBlood GlucoseBlood PressureBody Mass IndexCholesterol, HDLCholesterol, LDLCross-Over StudiesDouble-Blind MethodExerciseFemaleHumansHypercholesterolemiaInsulin ResistanceBlood GlucoseCholesterol, HDLCholesterol, LDLOlive OilPolyphenolsTriglyceridesHDL-C/HDL-P and LDL-P/HDL-P ratiosLipoprotein subclassesOlive oilPolyphenolsThyme

Identifiers

PMID26992050
PMCPMC4949304
OpenAlexW2299421211

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.